•  Summary 
  •  
  •  Actions 
  •  
  •  Committee Votes 
  •  
  •  Floor Votes 
  •  
  •  Memo 
  •  
  •  Text 
  •  
  •  LFIN 
  •  
  •  Chamber Video/Transcript 

A09519 Summary:

BILL NOA09519
 
SAME ASSAME AS S08869
 
SPONSORMcDonald
 
COSPNSR
 
MLTSPNSR
 
Amd §§3216, 3221 & 4303, Ins L
 
Requires certain health insurance policies include coverage for services provided by pharmacists related to contraceptives.
Go to top

A09519 Text:



 
                STATE OF NEW YORK
        ________________________________________________________________________
 
                                          9519
 
                   IN ASSEMBLY
 
                                    January 14, 2026
                                       ___________
 
        Introduced by M. of A. McDONALD -- read once and referred to the Commit-
          tee on Insurance
 
        AN  ACT  to  amend  the  insurance law, in relation to requiring certain
          health insurance policies include coverage services provided by  phar-
          macists related to contraceptives
 
          The  People of the State of New York, represented in Senate and Assem-
        bly, do enact as follows:

     1    Section 1. Item (v) of subparagraph (E) of paragraph 17 of  subsection
     2  (i)  of  section  3216  of the insurance law, as amended by section 3 of
     3  part M of chapter 57 of the laws of 2019, is amended to read as follows:
     4    (v) all FDA-approved contraceptive drugs, devices, and other products,
     5  including  all  over-the-counter  contraceptive  drugs,   devices,   and
     6  products as prescribed or as otherwise authorized under state or federal
     7  law;  voluntary sterilization procedures pursuant to 42 U.S.C. 18022 and
     8  identified in the  comprehensive  guidelines  supported  by  the  health
     9  resources  and  services  administration and thereby incorporated in the
    10  essential health benefits benchmark plan; patient  education  and  coun-
    11  seling  on  contraception;  and follow-up services related to the drugs,
    12  devices, products, and procedures covered under this clause,  including,
    13  but not limited to, management of side effects, counseling for continued
    14  adherence, and device insertion and removal. Except as otherwise author-
    15  ized  under  this  [clause]  item,  a  contract  shall  not  impose  any
    16  restrictions or delays on the  coverage  required  under  this  [clause]
    17  item.    However, where the FDA has approved one or more therapeutic and
    18  pharmaceutical equivalent, as defined by the FDA, versions of a  contra-
    19  ceptive  drug, device, or product, a contract is not required to include
    20  all such therapeutic  and  pharmaceutical  equivalent  versions  in  its
    21  formulary, so long as at least one is included and covered without cost-
    22  sharing and in accordance with this [clause] item.  If the covered ther-
    23  apeutic  and  pharmaceutical  equivalent  versions of a drug, device, or
    24  product are not available or are deemed medically inadvisable a contract
    25  shall provide coverage for an alternate therapeutic  and  pharmaceutical
    26  equivalent version of the contraceptive drug, device, or product without
    27  cost-sharing.
 
         EXPLANATION--Matter in italics (underscored) is new; matter in brackets
                              [ ] is old law to be omitted.
                                                                   LBD09936-05-6

        A. 9519                             2
 
     1    (a)  This  coverage shall include emergency contraception without cost
     2  sharing when provided pursuant to a prescription, or order under section
     3  sixty-eight hundred thirty-one of the education  law  or  when  lawfully
     4  provided over-the-counter.
     5    (b)  If  the  attending  health  care  provider, in [his or her] their
     6  reasonable professional judgment, determines that the use of a  non-cov-
     7  ered  therapeutic  or  pharmaceutical  equivalent  of a drug, device, or
     8  product is warranted, the health care provider's determination shall  be
     9  final.  The  superintendent  shall promulgate regulations establishing a
    10  process, including timeframes, for an insured, an insured's designee  or
    11  an  insured's  health care provider to request coverage of a non-covered
    12  contraceptive drug, device, or product. Such regulations shall include a
    13  requirement that insurers use an exception form that shall meet criteria
    14  established by the superintendent.
    15    (c) This coverage must allow for the dispensing of up to twelve months
    16  worth of a contraceptive at one time.
    17    (d) This coverage shall provide for an administrative fee to a pharma-
    18  cist who dispenses self-administered hormonal contraceptives pursuant to
    19  section sixty-eight hundred  one  of  the  education  law  and  provides
    20  related  services  no  less  than the current Medicaid rate for the same
    21  services.
    22    (e) For the purposes of this [clause] item, "over-the-counter  contra-
    23  ceptive  products"  shall mean those products provided for in comprehen-
    24  sive guidelines supported by the health resources and services  adminis-
    25  tration as of January twenty-first, two thousand nineteen.
    26    §  2.  Subparagraph  (A)  of paragraph 16 of subsection (l) of section
    27  3221 of the insurance law, as amended by section 1 of part M of  chapter
    28  57 of the laws of 2019, is amended to read as follows:
    29    (A)  Every  group  or  blanket  policy  that  provides  medical, major
    30  medical,  or  similar  comprehensive  type  coverage  [that  is  issued,
    31  amended,  renewed, effective or delivered on or after January first, two
    32  thousand twenty,] shall  provide  coverage  for  all  of  the  following
    33  services and contraceptive methods:
    34    (1) All FDA-approved contraceptive drugs, devices, and other products.
    35  This  includes  all  FDA-approved  over-the-counter contraceptive drugs,
    36  devices, and products as prescribed or  as  otherwise  authorized  under
    37  state or federal law. The following applies to this coverage:
    38    (a)  where the FDA has approved one or more therapeutic and pharmaceu-
    39  tical equivalent, as defined by the FDA,  versions  of  a  contraceptive
    40  drug,  device,  or product, a group or blanket policy is not required to
    41  include all such therapeutic and pharmaceutical equivalent  versions  in
    42  its  formulary,  so long as at least one is included and covered without
    43  cost-sharing and in accordance with this paragraph;
    44    (b) if the covered therapeutic and pharmaceutical equivalent  versions
    45  of  a drug, device, or product are not available or are deemed medically
    46  inadvisable a group or blanket policy  shall  provide  coverage  for  an
    47  alternate  therapeutic  and  pharmaceutical  equivalent  version  of the
    48  contraceptive drug, device, or  product  without  cost-sharing.  If  the
    49  attending health care provider, in [his or her] their reasonable profes-
    50  sional judgment, determines that the use of a non-covered therapeutic or
    51  pharmaceutical  equivalent  of  a drug, device, or product is warranted,
    52  the health care provider's determination shall be final. The superinten-
    53  dent shall promulgate  regulations  establishing  a  process,  including
    54  timeframes, for an insured, an insured's designee or an insured's health
    55  care  provider  to request coverage of a non-covered contraceptive drug,
    56  device, or product. Such regulations shall include  a  requirement  that

        A. 9519                             3
 
     1  insurers  use  an exception form that shall meet criteria established by
     2  the superintendent;
     3    (c)  this coverage shall include emergency contraception without cost-
     4  sharing when provided pursuant to a prescription or order under  section
     5  sixty-eight  hundred  thirty-one  of  the education law or when lawfully
     6  provided over the counter; [and]
     7    (d) this coverage must allow for the dispensing of up to twelve months
     8  worth of a contraceptive at one time; and
     9    (e) this coverage shall provide for an administrative fee to a pharma-
    10  cist who dispenses self-administered hormonal contraceptives pursuant to
    11  section sixty-eight hundred  one  of  the  education  law  and  provides
    12  related  services  no  less  than the current Medicaid rate for the same
    13  services;
    14    (2) Voluntary sterilization procedures pursuant to 42 U.S.C. 18022 and
    15  identified in the  comprehensive  guidelines  supported  by  the  health
    16  resources  and  services  administration and thereby incorporated in the
    17  essential health benefits benchmark plan;
    18    (3) Patient education and counseling on contraception; and
    19    (4) Follow-up services related to the drugs,  devices,  products,  and
    20  procedures  covered under this paragraph, including, but not limited to,
    21  management of side effects,  counseling  for  continued  adherence,  and
    22  device insertion and removal.
    23    §  3.  The  opening  paragraph  and subparagraph (A) of paragraph 1 of
    24  subsection (cc) of section 4303 of the  insurance  law,  as  amended  by
    25  section  2  of  part M of chapter 57 of the laws of 2019, are amended to
    26  read as follows:
    27    Every contract  that  provides  medical,  major  medical,  or  similar
    28  comprehensive type coverage [that is issued, amended, renewed, effective
    29  or  delivered  on  or  after  January first, two thousand twenty,] shall
    30  provide coverage for all of the  following  services  and  contraceptive
    31  methods:
    32    (A) All FDA-approved contraceptive drugs, devices, and other products.
    33  This  includes  all  FDA-approved  over-the-counter contraceptive drugs,
    34  devices, and products as prescribed or  as  otherwise  authorized  under
    35  state or federal law. The following applies to this coverage:
    36    (i)  where the FDA has approved one or more therapeutic and pharmaceu-
    37  tical equivalent, as defined by the FDA,  versions  of  a  contraceptive
    38  drug, device, or product, a contract is not required to include all such
    39  therapeutic  and pharmaceutical equivalent versions in its formulary, so
    40  long as at least one is included and covered without cost-sharing and in
    41  accordance with this subsection;
    42    (ii) if the covered therapeutic and pharmaceutical equivalent versions
    43  of a drug, device, or product are not available or are deemed  medically
    44  inadvisable a contract shall provide coverage for an alternate therapeu-
    45  tic  and  pharmaceutical  equivalent  version of the contraceptive drug,
    46  device, or product without cost-sharing. If the  attending  health  care
    47  provider, in [his or her] their reasonable professional judgment, deter-
    48  mines that the use of a non-covered therapeutic or pharmaceutical equiv-
    49  alent  of  a  drug,  device,  or  product  is warranted, the health care
    50  provider's  determination  shall  be  final.  The  superintendent  shall
    51  promulgate regulations establishing a process, including timeframes, for
    52  an  insured,  an insured's designee or an insured's health care provider
    53  to request coverage of a  non-covered  contraceptive  drug,  device,  or
    54  product.  Such regulations shall include a requirement that insurers use
    55  an exception form that shall meet criteria  established  by  the  super-
    56  intendent;

        A. 9519                             4
 
     1    (iii)  this  coverage  shall  include  emergency contraception without
     2  cost-sharing when provided pursuant to a  prescription  or  order  under
     3  section  sixty-eight  hundred  thirty-one  of  the education law or when
     4  lawfully provided over the counter; [and]
     5    (iv)  this  coverage  must  allow  for  the dispensing of up to twelve
     6  months worth of a contraceptive at one time; and
     7    (v) this coverage shall include an administrative fee to a  pharmacist
     8  who  dispenses  self-administered  hormonal  contraceptives  pursuant to
     9  section sixty-eight hundred  one  of  the  education  law  and  provides
    10  related  services  no  less  than the current Medicaid rate for the same
    11  services;
    12    § 4. This act shall take effect immediately and shall apply  to  poli-
    13  cies  and contracts issued, renewed, modified, altered or amended on and
    14  after such date.
Go to top